SEC Form 3 · accession 0001209191-15-078730
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Stroever
Director
Period of report
Sep 19, 2014
Accepted (ET)
Nov 5, 2015 · 4:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person is a member of the Board of Directors of the Issuer and is the President and Chief Executive Officer of Musculoskeletal Transplant Foundation, Inc. ("MTF") and, as such, advises MTF with respect to voting and investment decisions relating to the shares of stock owned by MTF but does not have or share voting and investment power over such shares. The Reporting Person disclaims beneficial ownership of the securities owned by MTF.